Mauna Kea Technologies Advances in Strategic and Operational Sectors

Mauna Kea Technologies recently updated its stakeholders on ongoing safeguard proceedings, strategic negotiations, and operational strides. The company is in constructive talks with financial partners to reach a viable resolution to its current challenges, with strategic negotiations underway for a Cellvizio® technology licensing deal in a promising therapeutic area.

Operationally, the CellTolerance franchise is gaining traction. Over 1,500 procedures have been completed, with new Centers of Excellence, including a prominent U.S. institution. Mauna Kea Technologies aims to maintain transparency as it progresses and continues to engage investors to ensure financial stability and support long-term growth plans.